Dr. Mohamed Eisa, MD

Dr. Eisa practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Eisa's NPI, 1558713057, was assigned on July 7, 2016. Dr. Eisa graduated from University of Khartoum Faculty of Medicine in 2010. Dr. Eisa holds Pennsylvania license MD478609.

Dr. Eisa's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Eisa's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Eisa is also affiliated with Oswego Hospital. The medical group on file is Department of Medicine. Dmand AI also links Dr. Eisa to 1 more hospital, 4 medical groups, 3 group practices and clinics, 1 therapy and rehab clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eisa practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Eisa's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Eisa is licensed in Pennsylvania.

CMS data shows 369 Medicare services from Dr. Eisa across 9 procedure codes in 2024, for 272 Medicare patients. Medicare paid $35,159 for them.

CMS counts 272 Medicare patients who saw Dr. Eisa in 2024. The largest group is 65 to 74, with 169 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eisa's median patient age at 59, with 51% women.

In 2024, Dr. Eisa wrote 941 Medicare Part D claims for 398 patients. 80% of them were for generic drugs. CMS names the drug for 824 of them, across 18 drugs with 11 or more claims each, at $88,471 in total drug cost. In 2023, CMS named 693 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Eisa for performance year 2024, reported through an alternative payment model (APM). Dr. Eisa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 67 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Eisa, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Eisa, published from 2018 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Enteral Nutrition, Cell Line and COVID-19. Dr. Eisa has published most often in Curr Gastroenterol Rep. Dr. Eisa's most frequent co-authors are Endashaw Mahmud Omer, MD, Ronnie Fass, MD and Matthew Alexander Heckroth, MD.

CMS Open Payments shows 150 general payments to Dr. Eisa from 25 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Phathom Pharmaceuticals, Inc. paid the most, $11,867.

Dr. Eisa graduated from University of Khartoum Faculty of Medicine in 2010.